Abstract
Menorrhagia (heavy menstrual bleeding) is a common gynaecological problem and has a major impact on women's general health and quality of life. Management of menorrhagia should aim to improve these aspects rather than focusing on actual reduction in menstrual blood loss. Actual menstrual blood loss (MBL) can only be measured precisely by the alkaline haematin method to extract its haemoglobin content. This is a sophisticated laboratory test and not practical for clinical use. In addition, blood loss only makes up to half of the total menstrual loss [1] and does not necessarily reflect the women's complaints and the adverse effect of heavy menstrual flow on their quality of life.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.